CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
T Cell Markers and B Cell Markers
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
B Cell Overview | Thermo Fisher Scientific - US
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
CD antigens expression in B cells | Sino Biological
B Cell Overview | Thermo Fisher Scientific - US
Introduction to Flow Cytometric Analysis | Flow Cytometry
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
CD19 - The Marker, the Antibodies | Bio-Rad
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
CD antigens expression in B cells | Sino Biological
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
CD19 - an overview | ScienceDirect Topics
JCI - Genes required for B cell development
B-cell development and expression of surface markers targeted by... | Download Scientific Diagram
Standing out from the crowd: How to identify plasma cells
A Guide to Breg Markers | Biocompare: The Buyer's Guide for Life Scientists
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma | Haematologica
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
